GPX4 and bronchopulmonary dysplasia: In a study by Huang et al., in 2022, miR-134-5p was found to be upregulated in bronchopulmonary dysplasia (BPD) in preterm infants, leading to ROS and Fe2+ accumulation and GPX4 downregulation in these patients.